Cannabinoid Encyclopedia

Focused research review

What does research say about CBC and skin health?

What evidence connects CBC with skin, dermatology, antimicrobial, or topical inflammatory outcomes?

Updated July 2026 21 research sources Human and early research

The short answer

What is the bottom line?

Research has examined CBC and skin health. This page brings together 6 human-study sources, 5 research reviews, and 5 lab, animal, or mechanism sources. The source set includes human research as well as earlier-stage studies. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about CBC and skin health.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on CBC and skin health covers Skin and inflammatory dermatology; those areas should not be combined into one claim. 1

  2. 2

    The source set includes human research as well as earlier-stage studies. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about CBC and skin health

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Too limited for a firm answer

Skin and inflammatory dermatology

This part of the literature focuses on Skin and inflammatory dermatology. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

6 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

5 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

5 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

Another 5 of 21 research sources could not be placed cleanly into those three groups from the recorded study details.

What these studies actually looked at

The research on CBC and skin health is not one kind of study. This source set includes 5 animal studies, 5 cell or laboratory studies, and 5 narrative or expert reviews. 3

The recorded populations or models include people or patients (7 sources), animal models (4 sources), and cells or tissue models (3 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is skin, dermatology, antimicrobial, or topical inflammatory outcomes (21 sources). Closely related outcome names can still describe different measurements. 5

The CBC and skin health source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

narrative or expert review

Cannabinoids as Antibacterial Agents: A Systematic and Critical Review of In Vitro Efficacy Against Streptococcus and Staphylococcus.

On this page, this source examines CBC and skin and inflammatory dermatology. 1

Study type
narrative or expert review
Population or model
cells or tissue models
Outcome focus
skin, dermatology, antimicrobial, or topical inflammatory outcomes
Evidence stage
evidence still limited

narrative or expert review

The Potential of Cannabichromene (CBC) as a Therapeutic Agent.

On this page, this source examines CBC and skin and inflammatory dermatology. 2

Study type
narrative or expert review
Outcome focus
skin, dermatology, antimicrobial, or topical inflammatory outcomes
Evidence stage
evidence still limited

cell or laboratory study

Cannabinoids: Therapeutic Applications, Mechanisms, and Challenges in Modern Medicine.

On this page, this source examines CBC and skin and inflammatory dermatology. 3

Study type
cell or laboratory study
Population or model
people or patients
Outcome focus
skin, dermatology, antimicrobial, or topical inflammatory outcomes
Evidence stage
mechanism-focused research

animal study

Design, synthesis, and biological evaluation of membrane-active cannabichromene derivatives as potent antibacterial agents.

On this page, this source examines CBC and skin and inflammatory dermatology. 4

Study type
animal study
Population or model
animal models
Outcome focus
skin, dermatology, antimicrobial, or topical inflammatory outcomes
Evidence stage
preclinical research

human research

Broad-spectrum bactericidal synergy of silver-cannabichromene-cannabigerol triple combinations against healthcare-associated pathogens.

On this page, this source examines CBC and skin and inflammatory dermatology. 5

Population or model
people or patients
Outcome focus
skin, dermatology, antimicrobial, or topical inflammatory outcomes
Evidence stage
human research

Safety and limits

What should readers keep in mind?

Research on CBC and skin health should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What evidence connects CBC with skin, dermatology, antimicrobial, or topical inflammatory outcomes?

Relevant research is collected here. The source set includes human research as well as earlier-stage studies. 7

Why is there not always a yes-or-no answer?

The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 8

Where can I read the original studies?

Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Cannabinoids as Antibacterial Agents: A Systematic and Critical Review of In Vitro Efficacy Against Streptococcus and Staphylococcus. narrative or expert review; evidence still limited PubMed 39596719 DOI 10.3390/antibiotics13111023
  2. 2
    The Potential of Cannabichromene (CBC) as a Therapeutic Agent. narrative or expert review; evidence still limited PubMed 38777605 DOI 10.1124/jpet.124.002166
  3. 3
    Cannabinoids: Therapeutic Applications, Mechanisms, and Challenges in Modern Medicine. cell or laboratory study; mechanism-focused research PubMed 42163693 DOI 10.2174/0109298673390667251201115054
  4. 4
    Design, synthesis, and biological evaluation of membrane-active cannabichromene derivatives as potent antibacterial agents. animal study; preclinical research PubMed 40580638 DOI 10.1016/j.ejmech.2025.117888
  5. 5
    Broad-spectrum bactericidal synergy of silver-cannabichromene-cannabigerol triple combinations against healthcare-associated pathogens. human research PubMed 41983582 DOI 10.1093/jambio/lxag092
  6. 6
    Cannabis-Based Phytocannabinoids: Overview, Mechanism of Action, Therapeutic Application, Production, and Affecting Environmental Factors. narrative or expert review; evidence still limited PubMed 39457041 DOI 10.3390/ijms252011258
  7. 7
    Synthetic Pathways to Non-Psychotropic Phytocannabinoids as Promising Molecules to Develop Novel Antibiotics: A Review. narrative or expert review; evidence still limited PubMed 37514074 DOI 10.3390/pharmaceutics15071889
  8. 8
    Therapeutic Potential of Minor Cannabinoids in Dermatological Diseases-A Synthetic Review. narrative or expert review; evidence still limited PubMed 37630401 DOI 10.3390/molecules28166149
  9. 9
    Biological activity of cannabichromene, its homologs and isomers. animal study; preclinical research PubMed 7298870 DOI 10.1002/j.1552-4604.1981.tb02606.x
  10. 10
    Cannabichromene as a Novel Inhibitor of Th2 Cytokine and JAK/STAT Pathway Activation in Atopic Dermatitis Models. animal study; mechanism-focused research PubMed 39769302 DOI 10.3390/ijms252413539
  11. 11
    Cannabidiol and Minor Phytocannabinoids: A Preliminary Study to Assess Their Anti-Melanoma, Anti-Melanogenic, and Anti-Tyrosinase Properties. animal study; mechanism-focused research PubMed 37242431 DOI 10.3390/ph16050648
  12. 12
    The antinociceptive activity and mechanism of action of cannabigerol. animal study; preclinical research PubMed 36916438 DOI 10.1016/j.biopha.2022.114163
See all 21 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Cannabinoids: Therapeutic Applications, Mechanisms, and Challenges in Modern Medicine. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 42163693
  2. The Potential of Cannabichromene (CBC) as a Therapeutic Agent. narrative or expert review; evidence still limited / 1 linked research note PubMed 38777605
  3. Therapeutic Potential of Minor Cannabinoids in Dermatological Diseases-A Synthetic Review. narrative or expert review; evidence still limited / 1 linked research note PubMed 37630401
  4. Design, synthesis, and biological evaluation of membrane-active cannabichromene derivatives as potent antibacterial agents. animal study; preclinical research / 1 linked research note PubMed 40580638
  5. The antinociceptive activity and mechanism of action of cannabigerol. animal study; preclinical research / 1 linked research note PubMed 36916438
  6. Cannabigerol and Cannabicyclol Block SARS-CoV-2 Cell Fusion. cell or laboratory study; evidence still limited / 1 linked research note PubMed 38885660
  7. Minor Cannabinoids as Inhibitors of Skin Inflammation: Chemical Synthesis and Biological Evaluation. evidence still limited / 1 linked research note PubMed 38889235
  8. Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 27094344
  9. Cannabichromene as a Novel Inhibitor of Th2 Cytokine and JAK/STAT Pathway Activation in Atopic Dermatitis Models. animal study; mechanism-focused research / 1 linked research note PubMed 39769302
  10. Cannabis-Based Phytocannabinoids: Overview, Mechanism of Action, Therapeutic Application, Production, and Affecting Environmental Factors. narrative or expert review; evidence still limited / 1 linked research note PubMed 39457041
  11. Cannabinoids as Antibacterial Agents: A Systematic and Critical Review of In Vitro Efficacy Against Streptococcus and Staphylococcus. narrative or expert review; evidence still limited / 1 linked research note PubMed 39596719
  12. Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 35628241
  13. Cannabidiol and Minor Phytocannabinoids: A Preliminary Study to Assess Their Anti-Melanoma, Anti-Melanogenic, and Anti-Tyrosinase Properties. animal study; mechanism-focused research / 1 linked research note PubMed 37242431
  14. Rare Phytocannabinoids Exert Anti-Inflammatory Effects on Human Keratinocytes via the Endocannabinoid System and MAPK Signaling Pathway. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 36769042
  15. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 1 - continuous bivariate analysis. evidence still limited / 1 linked research note PubMed 35354487
  16. Design and synthesis of amphiphilic cannabichromene derivatives with antimicrobial potential. evidence still limited / 1 linked research note PubMed 41202683
  17. Targeting the antioxidant, antimicrobial and anti-inflammatory activity of non-psychotropic Cannabis sativa L.: a comparison with chemotype V. evidence still limited / 1 linked research note PubMed 41121423
  18. Broad-spectrum bactericidal synergy of silver-cannabichromene-cannabigerol triple combinations against healthcare-associated pathogens. human research / 1 linked research note PubMed 41983582
  19. Synthetic Pathways to Non-Psychotropic Phytocannabinoids as Promising Molecules to Develop Novel Antibiotics: A Review. narrative or expert review; evidence still limited / 1 linked research note PubMed 37514074
  20. Spent Material Extractives from Hemp Hydrodistillation as an Underexplored Source of Antimicrobial Cannabinoids. evidence still limited / 1 linked research note PubMed 38927152
  21. Biological activity of cannabichromene, its homologs and isomers. animal study; preclinical research / 1 linked research note PubMed 7298870